Simultaneous T2-FLAIR and T1 Brain MRI With ENRAGED FLAIR in Multiple Sclerosis

计划入组 11 人 · 首次发布于 2026 年 7 月 7 日

FLAIR™ Delivery System Study

计划入组 30 人 · 首次发布于 2008 年 2 月 13 日

Usefulness of Gadovist-enhanced FLAIR Imaging

计划入组 60 人 · 首次发布于 2022 年 3 月 24 日

FLAIG, THOMAS, W, M.D.

United States

UK Flair Trial Demonstrates Superior Outcomes with Chemotherapy-Free Combination Therapy for Chronic Lymphocytic Leukaemia

MRD-Guided Ibrutinib-Venetoclax Therapy Shows Superior Outcomes in CLL Treatment: FLAIR Trial Results

Targeted Drug Combination Induces Remission in CLL Patients, Improving Survival and Quality of Life